International Stem Cell (ISCO) Income from Continuing Operations (2010 - 2026)
International Stem Cell (ISCO) recorded Income from Continuing Operations of -$69,000 in Q2 2026, compared with $129,000 a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
On a TTM basis, International Stem Cell's Income from Continuing Operations came in at -$231,000 as of Jun 30, 2026; for FY2025, it was -$418,000.
- Across earlier years, Income from Continuing Operations came in at -$213,000 in FY2024, -$802,000 in FY2023, -$318,000 in FY2022 and -$2.05 million in FY2021.
- Quarterly Income from Continuing Operations has ranged from -$641,000 in Q3 2021 to $129,000 in Q2 2025 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | International Stem Cell | 2.64 Mn | -1.33 Mn | 1.46 Mn | -69,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69,000.00 |
| Dec 31, 2025 | -348,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | -256,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -125,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | -214,000.00 |
| Dec 31, 2023 | -458,000.00 |
| Sep 30, 2023 | -131,000.00 |
| Jun 30, 2023 | -179,000.00 |
| Mar 31, 2023 | -34,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | -335,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -9,000.00 |
| Dec 31, 2021 | -364,000.00 |
| Sep 30, 2021 | -641,000.00 |
| Jun 30, 2021 | -445,000.00 |
API Access
International Stem Cell Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();